December 19, 2019 — The U.S. Food and Drug Administration (FDA) has granted breakthrough status for a novel ECG-based ...
Diagnostic and Interventional Cardiology DAIC
Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.
December 18, 2019 — Append Medical, developer of a novel left atrial appendage (LAA) closure device to minimize stroke ...
December 18, 2019 — BioVentrix, Inc., developer of the first less invasive system for left ventricular remodeling, today ...
December 16, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...
December 12, 2019 — Impulse Dynamics, developer of Optimizer Smart System for delivering CCM therapy, announced the ...
The overwhelming success story for transcatheter aortic valve replacement (TAVR) moving from a science project to ...
November 26, 2019 — Physicians from the University of New Mexico (UNM) and local emergency responders recently treated a ...
November 26, 2019 — The preliminary one-year results of the TRILUMINATE Pivotal Study for Abbott's TriClip device, a ...
November 21, 2019 — The U.S. Food and Drug Administration (FDA) has cleared the Medtronic In.Pact AV drug-coated balloon ...
Now, more than ever, the field of cardiology needs women.
But as the national need for more cardiologists overall ...
November 21, 2019 — At the American Heart Association Scientific Sessions 2019, Eko, a digital health company applying a ...
November 21, 2019 — People who experience cardiac arrests over the weekend are less likely to survive long enough to be ...
November 21, 2019 — Endotronix, a digital health and medical technology company dedicated to advancing the treatment of ...
It’s an exciting time in the heart failure (HF) world right now with the emergence of new therapies, including ...
November 21, 2019 — Merck announced the results from the Phase 3 VICTORIA Study evaluating the efficacy and safety of ...
December 19, 2019